SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002641
Filing Date
2019-04-26
Accepted
2019-04-26 17:19:04
Documents
7
Period of Report
2019-05-30
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238587zdef14a.htm DEF 14A 868064
2 G81352BGI001.GIF g81352bgi001.gif GRAPHIC 94950
3 G81352BGI002.GIF g81352bgi002.gif GRAPHIC 65626
4 G550641.JPG g550641.jpg GRAPHIC 8810
5 G323128.JPG g323128.jpg GRAPHIC 5850
6 G425132.JPG g425132.jpg GRAPHIC 12465
7 G555113.JPG g555113.jpg GRAPHIC 42147
  Complete submission text file 0001047469-19-002641.txt   1186226
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34620 | Film No.: 19772861
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1